Berry Street, a U.S. nutrition care company, has merged with India-based Healthify to form what executives call the largest insurance-covered AI metabolic health platform in the United States. The companies announced the deal on Monday and did not disclose its financial terms. The combined business will pair Healthify's artificial intelligence technology with Berry Street's national network of more than 2,000 clinicians.
Leadership and Brand Structure
Under the agreement, Berry Street founder Noah Kotlove and Healthify founder Tushar Vashisht will serve as co-CEOs. In the U.S., the combined company will continue to operate under the Berry Street brand, while the Healthify brand will remain active in India and other international markets. Kotlove said the two teams shared the same vision for metabolic health and decided to join forces rather than follow separate roadmaps.
Clinical Scale and AI Capabilities
Berry Street has built one of the largest networks of registered dietitians in the country, serving more than 200,000 patients through collaborations with Amazon, Walmart, health plans and consumer platforms. Healthify's platform has been refined through hundreds of millions of real dietitian-to-patient interactions and supports nutrition, sleep, stress and weight data in real time. The companies say the merger will combine clinical coverage infrastructure with consumer AI tools that have already demonstrated measurable outcomes.
GLP-1 Demand and Insurance Access
Berry Street entered the obesity and weight management market last year with its GLP-1 Nutrition Pathway Program, which lets patients work with doctors and access FDA-approved weight loss medications through insurance. According to KFF data, one in eight Americans is now on a GLP-1 medication, and the science shows these drugs work best with high-touch clinical oversight and nutrition guidance. Executives believe most Americans have lacked access to that combined experience until now.
AI Research and Novo Nordisk Support
Healthify offers an AI nutrition coach called Ria that is multimodal, multilingual and able to track food from a photograph in under one second. A peer-reviewed study with Stanford Medical School, described as the first paper to examine AI-only metabolic health outcomes, found measurable improvements in weight and metabolic markers among Ria users. Healthify has also built a GLP-1 weight management initiative that includes a patient support program with Novo Nordisk and is now its fastest-growing offering.
Medicare ACCESS Model Participation
Berry Street is among the first cohort of the Centers for Medicare and Medicaid Services ACCESS model, a new 10-year program for value-based chronic condition management. This model relies heavily on technology and artificial intelligence to serve large populations of patients. Kotlove said reimbursement rates are intentionally low, making AI an important tool to support Medicare beneficiaries in cardio-kidney-metabolic tracks.
Funding and Market Momentum
Berry Street raised a $50 million funding round in February 2025 from Northzone, Sofina and FJ Labs, while Healthify has raised more than $150 million according to Crunchbase. The combined entity enters a market shaped by artificial intelligence, GLP-1 weight loss drugs and the consumerization of healthcare. Healthify has served more than 45 million users across more than 20 cultures, giving the new company substantial global reach.
Vinod Khosla, founder of Khosla Ventures, said the combined platform will redefine metabolic care by pairing AI with a nationwide network of expert clinicians and insurance access. The company supports more than 30 conditions, including diabetes, heart health, weight loss and women's health, while integrating meal tracking, wearables and lab data between visits. The merger reflects a broader shift toward clinically supervised, insurance-backed AI health services rather than standalone consumer wellness apps.